Effectiveness of icotinib against non-small-cell lung cancer with uncommon EGFR mutations.

被引：2
|
作者：
Zhou, Shengyu
Hu, Xingsheng
Wang, Yan
Li Junling
Zhou, Liqiang
Hao, Xuezhi
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Beijing Key Lab Clin Study Anticanc Mol Targeted, Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21083
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
    Fang, Shu
    Wang, Zhehai
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611
  • [22] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
    Rafael Rosell
    Teresa Morán
    Enric Carcereny
    Vanessa Quiroga
    Miguel Ángel Molina
    Carlota Costa
    Susana Benlloch
    Miquel Tarón
    [J]. Clinical and Translational Oncology, 2010, 12 : 75 - 80
  • [23] EGFR Mutations in Non-Small-Cell Lung Cancer Find, Divide, and Conquer
    Morgensztern, Daniel
    Politi, Katerina
    Herbst, Roy S.
    [J]. JAMA ONCOLOGY, 2015, 1 (02) : 146 - 148
  • [24] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
    Rosell, Rafael
    Moran, Teresa
    Carcereny, Enric
    Quiroga, Vanessa
    Angel Molina, Miguel
    Costa, Carlota
    Benlloch, Susana
    Taron, Miquel
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (02): : 75 - 80
  • [25] First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea
    Kim, Mi-Hyun
    Choi, Chang Min
    Lee, Sung Yong
    Park, Cheol Kyu
    Chang, Yoon Soo
    Lee, Kye Young
    Kim, Seung Joon
    Yang, Sei Hoon
    Ryu, Jeong Seon
    Lee, Jeong Eun
    Lee, Shin Yup
    Park, Chan Kwon
    Lee, Sang Hoon
    Jang, Seung Hun
    Yoon, Seong Hoon
    Jang, Tae Won
    [J]. ANTICANCER RESEARCH, 2022, 42 (03) : 1615 - 1622
  • [26] Icotinib for Control of Leptomeningeal Carcinomatosis in Non-Small Cell Lung Cancer with Sensitive EGFR Mutations
    Fan, Yun
    Gong, Lei
    Huang, Zhiyu
    Miao, Lulu
    Xu, Yanjun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S648 - S648
  • [27] The Impact of EGFR Mutations. Treatment with ITKs in Non-Small Cell Lung Cancer Patients
    Garcia Manrique, T.
    Saavedra, O.
    Palazon Carrion, N.
    Perez Gago, C.
    Calvete, J.
    Carrillo, R.
    Valdivia Garcia, F. J.
    Vicente Baz, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2146 - S2146
  • [28] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Targeting EGFR in non-small-cell lung cancer
    Doroshow, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 200 - 202
  • [30] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
12345